Journal Mobile Options
Table of Contents
Vol. 78, No. 3, 2007
Issue release date: April 2007
Urol Int 2007;78:260–263

Is Second-Line Enuretic Alarm Therapy after Unsuccessful Pharmacotherapy Superior to First-Line Therapy in the Treatment of Monosymptomatic Nocturnal Enuresis?

Tuygun C. · Eroglu M. · Bakirtas H. · Gucuk A. · Zengin K. · Imamoglu A.
Department of Urology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Introduction: We aimed at comparing the success rates of primary enuretic alarm therapy with those of secondary alarm therapy after failed pharmacotherapy in the treatment of monosymptomatic nocturnal enuresis (MNE). Patients and Methods: We randomly applied enuretic alarm therapy in 35 MNE patients (group 1) and desmopressin therapy in 49 MNE patients (group 2). The success and rebound rates after 3 and 6 months were determined. We also applied enuretic alarm therapy as a secondary treatment in 19 group 2 patients with complete rebound after 6 months (group 3). The success rates of patients who have received primary and secondary enuretic alarm therapy were compared. Results: The success rates for groups 1 and 2 were 82.65 and 81.63%, respectively (p = 0.885), at 3 months and 54.28 and 26.53%, respectively (p = 0.007), at 6 months. The success rates in group 3 were 84.21 and 52.63%, respectively, at 3 and 6 months. When these success rates were compared between groups 1 and 3, no statistically significant difference was found (p = 1.000). Conclusion: Prior pharmacotherapy did not increase success rates of alarm therapy in our MNE patients.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Schmitt BD: Nocturnal enuresis. Pediatr Rev 1997;18:183–190.
  2. Tietjen DN, Husmann DA: Nocturnal enuresis: a guide to evaluation and treatment. Mayo Clin Proc 1996;71:857–862.
  3. Alon US: Nocturnal enuresis. Pediatr Nephrol 1995;9:94–103.
  4. Cossio SE: Enuresis. South Med J 2002;95:183–187.
  5. Neveus T, Läckgren G, Tuvemo T, et al: Enuresis – backround and treatment. Scand J Urol Nephrol Suppl 2000;206:1–44.

    External Resources

  6. Läckgren G, Hjämas K, van Gool J, et al: Nocturnal enuresis: a suggestion for a European treatment strategy. Acta Paediatr 1999;88:1–7.
  7. Radmayr C, Schlager A, Studen M, et al: Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol 2001;40:201–205.
  8. Fai-Ngo Ng C, Wong SN: Comparing alarms, desmopressin, and combined treatment in Chinese enuretic children. Pediatr Nephrol 2005;20:163–169.
  9. Bradbury M: Combination therapy for nocturnal enuresis with desmopressin and an alarm device. Scand J Urol Nephrol Suppl 1997;183:61–63.
  10. Woo SH, Park KH: Enuresis alarm treatment as a second line to pharmacotherapy in children with monosymptomatic nocturnal enuresis. J Urol 2004;171:2615–2617.
  11. Foxman B, Valdez RB, Brook RH: Childhood enuresis: prevalence, percevied impact, and prescribing treatments. Pediatrics 1986;77:482.
  12. Forsythe WI, Butler RJ: Fifty years of enuresis alarms. Arch Dis Child 1989;64:879–885.
  13. Butler R, Stenberg G: Treatment of childhood nocturnal enuresis: an examination of clinically relevant principles. BJU Int 2001;88:563.
  14. Johnson M: Nocturnal enuresis. Urol Nurs 1998;37:23–30.
  15. Devlin JB, O’Cathain C: Predicting treatment outcome in nocturnal enuresis. Arch Dis Child 1990;65:1158–1161.
  16. Bradbury MG, Meadow SR: Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatr 1995;84:1014.
  17. Bosson S, Lyth N: Nocturnal enuresis. Clin Evid 2003;9:407–414.

    External Resources

  18. Leebeek-Groenewegen A, Blom J, Sukhai R, et al: Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. J Urol 2001;166:2456–2458.
  19. Cendron M: Primary nocturnal enuresis: current. Am Fam Physician 1999;59:1205–1214.
  20. Schaumburg HL, Rittig S, Djurhuus JC: No relationship between family history of enuresis and response to desmopressin. J Urol 2001;166:2435–2437.
  21. Kruse S, Hellström AL, Hanson E, et al: Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: predictive factors. BJU Int 2001;88:572–576.
  22. Schmitt BD: Nocturnal enuresis. Pediatr Rev 1997;18:183–190; quiz 91.
  23. Ankjaer-Jensen A, Sejr TE: Costs of the treatment of enuresis nocturna: health economic consequences of alternative methods in the treatment of enuresis nocturna (in Danish). Ugeskr Laeger 1994;156:4355–4360.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00